<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">11999623</PMID>
        <DateCompleted>
            <Year>2003</Year>
            <Month>01</Month>
            <Day>15</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0012-4486</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>104</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2002</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Documenta ophthalmologica. Advances in ophthalmology</Title>
                <ISOAbbreviation>Doc Ophthalmol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Visual field constriction and electrophysiological changes associated with vigabatrin.</ArticleTitle>
            <Pagination>
                <MedlinePgn>151-70</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We investigated functional, morphological and electrophysiological changes in patients under anti-epileptic therapy with vigabatrin (VGB), a GABA aminotransferase inhibitor.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">20 epileptic patients treated with vigabatrin (age range 25-66 years) were enrolled in this study. The referrals were made by the treating neurologist, based on suspected or known visual field changes in these patients. Two patients had vigabatrin monotherapy, 18 patients were treated with vigabatrin in combination with other antiepileptic drugs. None of the patients reported visual complaints. Patients were examined with psychophysical tests including colour vision (Farnsworth D15), dark adaptation threshold, Goldmann visual fields and Tuebingen Automated Perimetry (90 degrees). A Ganzfeld ERG and an EOG following the ISCEV standard protocol were also obtained. Additionally, all patients were examined with the VERIS multifocal ERG including recordings of multifocal oscillatory potentials.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Visual acuity, anterior and posterior segments, colour vision and dark adaptation thresholds were normal in all patients. Of 20 patients, 18 presented visual field constriction. All patients with visual field defects revealed altered oscillatory potentials waveforms in the ERG, especially in those patients with marked visual field defects. Multifocal oscillatory potentials were also delayed in those patients. In some patients a delayed cone single flash response (6/20), a reduced mERG amplitude (12/20) and a reduced Arden ratio (9/20) were found.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present data indicate an effect of vigabatrin on the inner retinal layers. Since abnormalities of the oscillatory potentials were seen in all patients with visual field defects a dysfunction of GABA-ergic retinal cell transmission might be assumed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Besch</LastName>
                    <ForeName>Dorothea</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuro-Ophthalmology and Pathophysiology of Vision, University Eye Hospital, TÃ¼bingen, Germany. dorothea.besch@uni-tuebingen.de</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kurtenbach</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Apfelstedt-Sylla</LastName>
                    <ForeName>Eckart</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sadowski</LastName>
                    <ForeName>Bettina</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dennig</LastName>
                    <ForeName>Dieter</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Asenbauer</LastName>
                    <ForeName>Christiane</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zrenner</LastName>
                    <ForeName>Eberhart</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schiefer</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Doc Ophthalmol</MedlineTA>
            <NlmUniqueID>0370667</NlmUniqueID>
            <ISSNLinking>0012-4486</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>GR120KRT6K</RegistryNumber>
                <NameOfSubstance UI="D020888">Vigabatrin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004585" MajorTopicYN="N">Electrooculography</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004596" MajorTopicYN="N">Electroretinography</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020888" MajorTopicYN="N">Vigabatrin</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014794" MajorTopicYN="N">Visual Fields</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2002</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>10</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2003</Year>
                <Month>1</Month>
                <Day>16</Day>
                <Hour>4</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2002</Year>
                <Month>5</Month>
                <Day>10</Day>
                <Hour>10</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">11999623</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Epilepsia. 1997 Mar;38(3):301-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9070592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vision Res. 1968 Jun;8(6):633-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4978009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmology. 1999 Sep;106(9):1792-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10485552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1996 Jan;46(1):54-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8559421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epilepsia. 1999 Dec;40(12):1784-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10612345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jan 18;314(7075):180-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9022432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1998 Jul 18;317(7152):206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9665915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 1989 Mar 13;98(1):29-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2710396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1999 May 12;52(8):1713-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10331710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nervenarzt. 1995 Feb;66(2):89-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7715759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1998 Aug 15;352(9127):546</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9716066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jun 7;314(7095):1694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9193313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):716-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10567485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurol. 1997 Oct;244(10):666-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9402546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1999 Dec 10;53(9):2082-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10599785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1999 Apr 12;52(6):1201-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10214744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vision Res. 1987;27(6):859-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3499028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jun 7;314(7095):1693-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9193312</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1998 Jan 17;316(7126):232-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9468716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1999 Aug 7;354(9177):486</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10465180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Pathol. 1987;15(2):143-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3616399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jun 7;314(7095):1693</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9193311</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Ophthalmol. 1998 Jun;116(6):817-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9639460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Doc Ophthalmol. 1998-1999;97(2):143-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10765968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vis Neurosci. 1995 Nov-Dec;12(6):1013-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8962824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1999 Sep 22;53(5):922-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10496247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Doc Ophthalmol. 1998-1999;97(2):179-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10765970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuroreport. 1996 Nov 4;7(15-17):2683-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8981447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Seizure. 1992 Sep;1(3):163-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1344761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vision Res. 1992 Mar;32(3):433-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1604830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Ophthalmol. 1993 May;111(5):601-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8489436</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1998 Mar;50(3):614-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9521245</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Pathol. 1990;18(2):225-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2399411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jun 7;314(7095):1694-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9193315</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1998 Jan 17;316(7126):233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9468717</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Jun 7;314(7095):1694</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9193314</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>